Oriola Oyj (LON:0NES)

Market Cap	176.41M
Revenue (ttm)	1.61B
Net Income (ttm)	-23.65M
Shares Out	n/a
EPS (ttm)	-0.13
PE Ratio	n/a
Forward PE	10.93
Dividend	0.06 (5.51%)
Ex-Dividend Date	Apr 3, 2025

Volume	31,528
Average Volume	11,454
Open	1.070
Previous Close	1.072
Day's Range	1.070 - 1.084
52-Week Range	0.877 - 1.220
Beta	0.59
RSI	38.27
Earnings Date	Feb 25, 2026

About Oriola Oyj

Oriola Oyj engages in the wholesale of pharmaceuticals and health products in Sweden, Finland, and internationally. The company also distributes vitamins, food and food supplements, sports nutrients, wound care, beauty, and makeup related products; vaccines; and over-the-counter products. In addition, it provides pharmaceutical logistics; special licensed medicine importing, dose dispensing, and research pharmacy services; and commercial data, clinical trial, regulatory affairs and quality, medical and scientific affairs, market access and tend...

• Industry: Medical - Equipment & Services
• Sector: Healthcare
• Founded: 1907
• Employees: 934
• Stock Exchange: London Stock Exchange
• Ticker Symbol: 0NES

Financial Performance

In 2024, Oriola Oyj's revenue was 1.68 billion, an increase of 12.45% compared to the previous year's 1.50 billion. Losses were -20.10 million, -2.90% less than in 2023.

Financial numbers in EUR